177 related articles for article (PubMed ID: 30734364)
1. Social media discussions provide new insight about perceptions of hydroxyurea in the sickle cell community.
Walker AL; Gaydos LM; Farzan R; De Castro L; Jonassaint C
Am J Hematol; 2019 May; 94(5):E134-E136. PubMed ID: 30734364
[No Abstract] [Full Text] [Related]
2. Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.
Zahr RS; Hankins JS; Kang G; Li C; Wang WC; Lebensburger J; Estepp JH
Am J Hematol; 2019 Jan; 94(1):E27-E29. PubMed ID: 30359463
[No Abstract] [Full Text] [Related]
3. Hydroxyurea marketed for sickle cell anemia.
Am J Health Syst Pharm; 1998 May; 55(9):875. PubMed ID: 9588244
[No Abstract] [Full Text] [Related]
4. Hydroxyurea for sickle cell anemia.
Naina HV; Harris S
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
[No Abstract] [Full Text] [Related]
5. Long-term use of hydroxyurea for sickle cell anemia.
Lee DA; Mueller BU
JAMA; 2003 Aug; 290(6):753-4; author reply 754. PubMed ID: 12915425
[No Abstract] [Full Text] [Related]
6. Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease.
Pashankar FD; Manwani D; Lee MT; Green NS
J Pediatr Hematol Oncol; 2015 Apr; 37(3):242-3. PubMed ID: 25222060
[No Abstract] [Full Text] [Related]
7. Hydroxyurea for Sickle Cell Disease: Now Is the Time!
Strouse JJ
South Med J; 2016 Sep; 109(9):535-7. PubMed ID: 27598356
[No Abstract] [Full Text] [Related]
8. Hydroxyurea and new agents for the treatment of sickle cell disease.
Rodgers GP
Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
[No Abstract] [Full Text] [Related]
9. [Treatment with hydroxyurea has revolutionized the evolution of sickle cell disease ].
Bartolucci P; de Montalembert M
Rev Prat; 2014 Oct; 64(8):1127-8. PubMed ID: 25510141
[No Abstract] [Full Text] [Related]
10. Experts urge wider use of hydroxyurea for sickle cell disease.
Traynor K
Am J Health Syst Pharm; 2008 Apr; 65(7):592-3. PubMed ID: 18359960
[No Abstract] [Full Text] [Related]
11. Hydroxyurea for the treatment of sickle cell anemia.
Platt OS
N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
[No Abstract] [Full Text] [Related]
12. Long-term use of hydroxyurea for sickle cell anemia.
Feldman L; Allen S; Westerman M; Feldman L; Gilman-Sachs A; Beaman K
JAMA; 2003 Aug; 290(6):752-3; author reply 754. PubMed ID: 12915423
[No Abstract] [Full Text] [Related]
13. Hydroxyurea and sickle cell disease: a chance for every patient.
Weiner DL; Brugnara C
JAMA; 2003 Apr; 289(13):1692-4. PubMed ID: 12672739
[No Abstract] [Full Text] [Related]
14. Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
Elsherif L; Scott LC; Wichlan D; Jones SK; Mathias JG; Shen JH; Smeltzer MP; Ataga KI
Br J Haematol; 2021 Aug; 194(3):e71-e73. PubMed ID: 34231209
[No Abstract] [Full Text] [Related]
15. Long-term use of hydroxyurea for sickle cell anemia.
Hagar W
JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
[No Abstract] [Full Text] [Related]
16. Hydroxyurea, sickle cell disease and renal transplantation.
Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
[No Abstract] [Full Text] [Related]
17. European register of patients with sickle cell disease treated with hydroxyurea is being set up.
Davies SC; Roberts-Harwood M
BMJ; 1998 Aug; 317(7157):541-2. PubMed ID: 9712619
[No Abstract] [Full Text] [Related]
18. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
Okam MM; Ebert BL
Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
[TBL] [Abstract][Full Text] [Related]
19. Treating sickle cell anaemia with hydroxycarbamide.
Pollack S
Br J Haematol; 2014 Jan; 164(2):296-7. PubMed ID: 24116862
[No Abstract] [Full Text] [Related]
20. Sickle cell paths converge on hydroxyurea.
Platt OS
Nat Med; 1995 Apr; 1(4):307-8. PubMed ID: 7585059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
